标普和纳斯达克内在价值 联系我们
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← 返回所有股票

NGM Biopharmaceuticals, Inc. NGM NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
49/100
3/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$16.50
+971.4%

共有 50 笔近期内部人交易记录记录，涉及 NGM Biopharmaceuticals, Inc. (NGM), 包括 26 笔买入 和 24 笔卖出. 内部人买入总额为 $5.19M 内部人卖出总额为 $20.6M.

近期活跃的重要内部人包括 Goeddel David V, Rieflin William Jl, Perlmutter Roger M. 内部人交易记录可以揭示公司管理层对股票估值和未来前景的看法.

内部人交易记录 — NGM

日期 姓名 职位 交易类型 股数 平均价格 总价值 持股数量
2024-04-05 Goeddel David V 10 Percent Owner 股份退回 16,806 $20.37 $342.34K -
2024-04-05 Rieflin William Jl Director 股份退回 225,000 $8.14 $1.83M -
2024-04-05 Perlmutter Roger M Director 股份退回 24,222 $13.35 $323.36K -
2024-04-05 Column Group L P 10 Percent Owner 股份退回 44,000 - - -
2024-04-05 Pierce Valerie L See Remarks 股份退回 147,000 $4.36 $640.92K -
2024-04-05 Viret Jean-frederic Chief Financial Officer 股份退回 450,000 $0.77 $346.5K -
2024-04-05 Lieu Hsiao D Chief Medical Officer 股份退回 159,000 $4.36 $693.24K -
2024-04-05 Hooper Suzanne Sawochka Director 股份退回 25,000 $12.06 $301.5K -
2024-04-05 Guyer Shelly D Director 股份退回 16,806 $20.37 $342.34K -
2024-04-05 Column Group Gp, Lp 10 Percent Owner 股份退回 44,000 - - -
2024-04-05 Woodhouse David J Chief Executive Officer 股份退回 500,000 $4.36 $2.18M -
2024-04-05 Ho Carole Director 股份退回 39,515 $20.66 $816.38K -
2024-04-05 Tcg Opportunity Iii Gp, Llc 10 Percent Owner 股份退回 44,000 - - -
2024-04-05 Perlich Irene Principal Accounting Officer 股份退回 20,000 $1.07 $21.4K -
2024-01-16 Pierce Valerie L SVP, Gc & Cco RSU 预扣税 5,021 $1.34 $6.73K 55,374
2024-01-16 Lieu Hsiao D EVP, Chief Medical Officer RSU 预扣税 5,430 $1.34 $7.28K 54,254
2024-01-16 Woodhouse David J Chief Executive Officer RSU 预扣税 13,032 $1.34 $17.46K 131,822
2024-01-16 Perlich Irene Principal Accounting Officer RSU 预扣税 1,025 $1.34 $1.37K 8,975
2023-12-01 Viret Jean-frederic Chief Financial Officer 限制性股票授予 (RSU) 450,000 $0.77 $346.5K 450,000
2023-11-16 Goeddel David V 10 Percent Owner 知情买入 1,460 $0.62 $906.81 134,180
2023-11-16 Column Group L P 10 Percent Owner 知情买入 5,840 $0.62 $3.63K 949,862
2023-11-15 Goeddel David V 10 Percent Owner 知情买入 2,720 $0.71 $1.92K 132,720
2023-11-15 Column Group L P 10 Percent Owner 知情买入 16,791 $0.71 $11.88K 944,022
2023-11-06 Pierce Valerie L SVP, Gc & Cco 股份退回 150,000 $15.20 $2.28M -
2023-11-06 Lieu Hsiao D EVP, Chief Medical Officer 股份退回 100,000 $31.93 $3.19M -
2023-11-06 Woodhouse David J Chief Executive Officer 股份退回 400,000 $16.47 $6.59M -
2023-11-06 Perlich Irene Principal Accounting Officer 股份退回 35,000 $15.20 $532K -
2023-11-03 Viret Jean-frederic Chief Financial Officer 处置 - - - 38
2023-09-15 Perlich Irene Principal Accounting Officer 处置 30,000 $4.36 $130.8K -
2023-05-10 Goeddel David V 10 Percent Owner 限制性股票授予 (RSU) 78,407 $3.69 $289.32K 78,407
2023-05-10 Rieflin William Jl Director 限制性股票授予 (RSU) 78,407 $3.69 $289.32K 78,407
2023-05-10 Perlmutter Roger M Director 限制性股票授予 (RSU) 78,407 $3.69 $289.32K 78,407
2023-05-10 Hooper Suzanne Sawochka Director 限制性股票授予 (RSU) 78,407 $3.69 $289.32K 78,407
2023-05-10 Guyer Shelly D Director 限制性股票授予 (RSU) 78,407 $3.69 $289.32K 78,407
2023-05-10 Ho Carole Director 限制性股票授予 (RSU) 78,407 $3.69 $289.32K 78,407
2023-03-02 Pierce Valerie L SVP, Gc & Cco 限制性股票授予 (RSU) 49,000 - - 55,667
2023-03-02 Lieu Hsiao D SVP, Chief Medical Officer 限制性股票授予 (RSU) 53,000 - - 55,605
2023-03-02 Woodhouse David J Chief Executive Officer 限制性股票授予 (RSU) 127,200 - - 144,854
2023-03-02 Chen Jin-long Chief Scientific Officer 限制性股票授予 (RSU) 175,000 $4.36 $763K 175,000
2023-03-02 Nolan Mangini Siobhan President and CFO 限制性股票授予 (RSU) 76,000 - - 76,000
2023-01-31 Goeddel David V 10 Percent Owner 知情买入 176,730 $5.00 $883.4K 927,231
2023-01-31 Column Group L P 10 Percent Owner 知情买入 176,730 $5.00 $883.4K 927,231
2023-01-30 Goeddel David V 10 Percent Owner 知情买入 7,542 $5.00 $37.71K 750,501
2023-01-30 Column Group L P 10 Percent Owner 知情买入 7,542 $5.00 $37.71K 750,501
2023-01-23 Goeddel David V Director 知情买入 9,900 $5.00 $49.49K 742,959
2023-01-23 Column Group L P Director 知情买入 9,900 $5.00 $49.49K 742,959
2023-01-20 Goeddel David V Director 知情买入 500 $5.00 $2.5K 733,059
2023-01-20 Column Group L P Director 知情买入 500 $5.00 $2.5K 733,059
2023-01-19 Goeddel David V Director 知情买入 37,639 $5.00 $188.1K 732,559
2023-01-19 Column Group L P Director 知情买入 37,639 $5.00 $188.1K 732,559
■ 知情交易 — 公开市场买卖（最具参考价值） ■ 非知情买入 — 奖励、期权行权、转换 ■ 非知情卖出 — 税务代扣、归属出售 ■ 中性 — 礼赠、信托、到期

其他人也在看

ERAS
ERAS
Erasca, Inc.
$18.20
+1.96%
 MLYS
MLYS
Mineralys Therapeutics, Inc.
$30.42
+11.35%
 GLUE
GLUE
Monte Rosa Therapeutics, Inc.
$18.23
+4.17%
 SANA
SANA
Sana Biotechnology, Inc.
$3.44
-1.15%
 LYEL
LYEL
Lyell Immunopharma, Inc.
$23.84
+2.01%
 ASMB
ASMB
Assembly Biosciences, Inc.
$29.81
+1.26%
 KROS
KROS
Keros Therapeutics, Inc.
$11.71
+1.39%
 RZLT
RZLT
Rezolute, Inc.
$3.59
+1.13%
联系我们
🎓
SharesGrow 学院
学习如何计算内在价值，发现被低估的股票。
每周在线课程
📧 [email protected]
📞 +65 8912 8000
给我们留言